Robertson JFR et al considered that the limitations of study design may be of much concern, such as absence of an established biomarker and deficiency of hyperglycaemia as well as growth hormone concentrations measurement [14]. The gene discussed is GH1; the disease is hyperinsulinemic hypoglycemia, familial, 4.